Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 9.

Journal Article

Augsburger, Daniela, Nelson, Peter J., Kalinski, Thomas, Udelnow, Andrej, Knoesel, Thomas, Hofstetter, Monika, Qin, Ji Wei, Wang, Yan, Sen Gupta, Arvid, Bonifatius, Susanne, Li, Minglun, Bruns, Christiane J. and Zhao, Yue (2017). Current diagnostics and treatment of fibrosarcoma -perspectives for future therapeutic targets and strategies. Oncotarget, 8 (61). S. 104638 - 104654. ORCHARD PARK: IMPACT JOURNALS LLC. ISSN 1949-2553

Niess, Hanno, Thomas, Michael N., Schiergens, Tobias S., Kleespies, Axel, Jauch, Karl-Walter, Bruns, Christiane, Werner, Jens, Nelson, Peter J. and Angele, Martin K. (2016). Genetic engineering of mesenchymal stromal cells for cancer therapy: turning partners in crime into Trojan horses. Innov. Surg. Sci., 1 (1). S. 19 - 33. BERLIN: WALTER DE GRUYTER GMBH. ISSN 2364-7485

Wang, Yan, Zhao, Yue, Herbst, Andreas, Kalinski, Thomas, Qin, Jiwei, Wang, Xiaoyan, Jiang, Zhenzhong, Benedix, Frank, Franke, Sabine, Wartman, Thomas, Camaj, Peter, Halangk, Walter, Kolligs, Frank T., Jauch, Karl W., Nelson, Peter J. and Bruns, Christiane J. (2016). miR-221 Mediates Chemoresistance of Esophageal Adenocarcinoma by Direct Targeting of DKK2 Expression. Ann. Surg., 264 (5). S. 804 - 815. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1528-1140

Wang, Zhefang, Qin, Jie, Zhao, Jiangang, Li, Jiahui, Li, Dai, Popp, Marie, Popp, Felix, Alakus, Hakan, Kong, Bo, Dong, Qiongzhu, Nelson, Peter J., Zhao, Yue and Bruns, Christiane J. (2020). Inflammatory IFIT3 renders chemotherapy resistance by regulating post-translational modification of VDAC2 in pancreatic cancer. Theranostics, 10 (16). S. 7178 - 7193. LAKE HAVEN: IVYSPRING INT PUBL. ISSN 1838-7640

Zhao, Yue, Dong, Qiongzhu, Li, Jiahui, Zhang, Kaili, Qin, Jie, Zhao, Jiangang, Sun, Qiye, Wang, Zhefang ORCID: 0000-0002-2297-2586, Wartmann, Thomas, Jauch, Karl Walter, Nelson, Peter J., Qin, LunXiu and Bruns, Christiane (2018). Targeting cancer stem cells and their niche: perspectives for future therapeutic targets and strategies. Semin. Cancer Biol., 53. S. 139 - 156. LONDON: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD. ISSN 1096-3650

Zhao, Yue, Li, Jiahui, Li, Dai, Wang, Zhefang, Zhao, Jiangang, Wu, Xiaolin, Sun, Qiye, Lin, Peter Ping, Plum, Patrick, Damanakis, Alexander ORCID: 0000-0002-1155-5541, Gebauer, Florian, Zhou, Menglong, Zhang, Zhen, Schloesser, Hans, Jauch, Karl-Walter, Nelson, Peter J. and Bruns, Christiane J. (2020). Tumor biology and multidisciplinary strategies of oligometastasis in gastrointestinal cancers. Semin. Cancer Biol., 60. S. 334 - 344. LONDON: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD. ISSN 1096-3650

Zheng, Yan, Wu, Chao, Yang, Jimeng, Zhao, Yue, Jia, Huliang, Xue, Min, Xu, Da, Yang, Feng, Fu, Deliang, Wang, Chaoqun, Hu, Beiyuan, Zhang, Ze, Li, Tianen, Yan, Shican, Wang, Xuan, Nelson, Peter J., Bruns, Christiane, Qin, Lunxiu and Dong, Qiongzhu (2020). Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer. Signal Transduct. Target. Ther., 5 (1). LONDON: NATURE PUBLISHING GROUP. ISSN 2059-3635

von Einem, Jobst C., Peter, Sylvia, Guenther, Christine, Volk, Hans-Dieter ORCID: 0000-0002-7743-6668, Guertz, Gerald, Salat, Christoph, Stoetzer, Oliver, Nelson, Peter J., Michl, Marlies, Modest, Dominik P., Holch, Julian W., Angele, Martin, Bruns, Christiane, Niess, Hanno and Heinemann, Volker (2017). Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1-a phase I, first in human, first in class trial. Oncotarget, 8 (46). S. 80156 - 80167. ORCHARD PARK: IMPACT JOURNALS LLC. ISSN 1949-2553

von Einem, Jobst Christian, Guenther, Christine, Volk, Hans-Dieter ORCID: 0000-0002-7743-6668, Gruetz, Gerald, Hirsch, Daniela, Salat, Christoph, Stoetzer, Oliver, Nelson, Peter J., Michl, Marlies, Modest, Dominik P., Holch, Julian W., Angele, Martin, Bruns, Christiane, Niess, Hanno and Heinemann, Volker (2019). Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT-ME-1 trial. Int. J. Cancer, 145 (6). S. 1538 - 1547. HOBOKEN: WILEY. ISSN 1097-0215

This list was generated on Sun Feb 28 05:04:30 2021 CET.